Several studies in the following years demonstrated that targeting TNF by specific monoclonal antibodies improved insulin sensitivity and improved hepatic steatosis, which is frequently observed in obesity and obese mice [21,22]. The gene discussed is TNF; the disease is obesity due to melanocortin 4 receptor deficiency.